Penczek Ronald W's Form 4 filing
Elevance Health, Inc. (ELV) · filed Feb 8, 2022
- Accession no.
- 0001156039-22-000006
- Filed
- Feb 8, 2022
- Trade date
- Feb 7, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.25M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Penczek Ronald WCIK 0001659075 | Officer (CAO & Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +818 | $232.04 | +$189,808.72 | 2,830 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +935 | $307.68 | +$287,680.8 | 3,765 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +357 | $166.97 | +$59,608.29 | 4,122 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +653 | $271.27 | +$177,139.31 | 4,775 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −2,763 | $453.48 | −$1,252,965.24 | 2,012 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −818 | $0.00 | $0 | 0 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −935 | $0.00 | $0 | 468 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −357 | $0.00 | $0 | 0 | Direct | |
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −653 | $0.00 | $0 | 1,307 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.